Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity and primary biliary cirrhosis.

I R Mackay1

  • 1Department of Biochemistry and Molecular Biology, Monash University, Victoria, 3800, Australia.

Bailliere'S Best Practice & Research. Clinical Gastroenterology
|September 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes.

Autoimmunity·2003
Same author

Humanism and the suffering of the people.

Internal medicine journal·2003
Same author

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2003
Same author

A dietary cause of type 1 diabetes: unearthing a new twist to the tale.

Diabetes technology & therapeutics·2002
Same author

Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.

Journal of gastroenterology and hepatology·2002
Same author

Dietary microbial toxins and type 1 diabetes--a new meaning for seed and soil.

Diabetologia·2001

Primary biliary cirrhosis (PBC) involves autoantibodies targeting mitochondria and nuclear antigens. A key finding is the accumulation of pyruvate dehydrogenase complex-E2 (PDC-E2) material on biliary cells, suggesting a specific autoimmune target.

Area of Science:

  • Immunology
  • Hepatology
  • Autoimmune Diseases

Background:

  • Primary biliary cirrhosis (PBC) is an autoimmune liver disease with a history dating back to 1851.
  • Autoimmunity in PBC is characterized by autoantibodies to mitochondria (AMA) and nuclear antigens (ANA).
  • AMA target E2 subunits of 2-oxoacid dehydrogenase complexes, notably pyruvate dehydrogenase complex (PDC-E2), which contains key B- and T-cell epitopes.

Purpose of the Study:

  • To review the historical context and immunological basis of primary biliary cirrhosis.
  • To explore the mechanisms of self-tolerance failure in PBC.
  • To investigate potential pathogenic pathways, including the role of PDC-E2 accumulation.

Main Methods:

  • Historical review of PBC research.

Related Experiment Videos

  • Analysis of autoantibody targets (AMA and ANA) in PBC patients.
  • Examination of self-tolerance mechanisms in autoimmune diseases.
  • Review of genetic and environmental influences on PBC.
  • Investigation of PDC-E2 localization in biliary epithelial cells (BECs).

    • Main Results:

    • PBC involves autoantibodies against mitochondrial (AMA) and nuclear (ANA) antigens.
    • AMA frequently target PDC-E2, a complex with a critical epitope for immune response.
    • ANA react with centromeric, nuclear dot, and nuclear pore complex proteins.
    • Failure in self-tolerance mechanisms contributes to PBC pathogenesis.
    • Genetic factors (familial occurrences, HLA associations) and environmental factors are implicated.
    • Unique accumulation of PDC-E2-like material on BECs is observed in PBC.

    Conclusions:

    • The accumulation of PDC-E2 on BECs presents a plausible tissue-specific target for autoimmune attack in PBC.
    • Understanding these autoimmune mechanisms is crucial for developing targeted therapies for PBC.
    • Further research is needed to elucidate the origin of PDC-E2 accumulation and its precise role in PBC pathogenesis.